(PharmaNewsWire.Com, December 01, 2017 ) According to the report Europe in-Vitro Diagnostics Market, published by Market Data Forecast, the Europe market is projected to reach USD 16.01 billion by 2021, at a CAGR of 5.10 % from 2016 to 2021.
IVD market include medical devices and accessories that are used to perform samples of blood, urine, or tissue taken from the human body in order to help detect signs of any possible infection, diagnose a medical condition, prevent disease, and monitor effectiveness and status of patients during drug therapies.
The devices range from simple tests to sophisticated DNA based technologies which include reagents, calibrators, control materials, kits, software, and other related instruments. Molecular Banking, Molecular assays, Point of care testing, tissue based testing, and hematology are some of the numerous applications of this market.
Europe In-Vitro Diagnostics Market: Drivers & Restraints
The In-Vitro Diagnostics market growth is likely to propagate in the future as per current trends of increase in the technological advancements and innovations. That, along with the increasing predominance of chronic diseases is boosting the demand for the solutions which are only possible with timely diagnostics through proper diagnostic technologies.
Technological advancements in the field of diagnostics have been made possible with increased government spending on healthcare as well as private investments, finances and grants for healthcare research. Developments of new biomarkers, increase in disease incidences and ageing population, as well as increased insurance and spending in emerging nations are also propelling the market. Lack of awareness and the unavailability of proper expert labor are probable to limit the market growth.
Some of the significant technologies incorporated in in-vitro diagnostics are PCR, immunoassays, and sequencing technologies. In vitro diagnostics plays a significant role in risk assessment, and monitoring of diseases. Great advances have been achieved, particularly in the fields of clinical immunology where Recombinant allergens have been investigated in diagnosing asthma and food, pollen-induced and insect based allergies, in in-vitro testing. The in-vitro diagnostics market comprises of several tests such as thyroid function tests, renal function tests, lipid profiling, liver function tests, basic metabolism tests, immunoassays, ELISA, radio Immunoassay, florescent Immunoassay (FIA), hematology, full blood count (RBC, WBC, and platelets), bone marrow testing, blood coagulation tests, biopsy, microbiology, and other IVD techniques.
Europe In-Vitro Diagnostics Market: Region-wise Outlook
On the basis of Geography, the European market for In-Vitro diagnostics is segmented into United Kingdom, Germany, France, Italy and Spain. Trends in this part of the world affect product decisions and company financial performance in others. The large share of this region can be attributed to presence of developed healthcare systems and increasing acceptance of personalized medicine, and growing adoption of technologically advanced products in this region.
Key Questions Answered
What are the major In-Vitro Diagnostics applications currently driving the market?
Which companies are currently dominating the market right now? What is the best market entry strategy to be followed for new entrants?
What is the competitive landscape scenario for the European In-Vitro Diagnostics market?
What are the latest technologies that are in the process of being developed that could have a significant impact on the market?
Which product segment is currently dominating in Europe? Which segments are expected to dominate in the next five years?
Which market leaders occupy the highest market share in Europe? Which ones dominate the global market as well and which are the local dark horses?
Europe In-Vitro Diagnostics Market: Key Players
The key players in this market are Roche Diagnostics (Switzerland), Abbott Laboratories (U.S.), Siemens Healthineers, Danaher Corporation, Thermo Fisher Scientific, Inc., Sysmex Corporation, Bio-Rad Laboratories, Inc., bioMιrieux, and Becton, Dickinson and Company, Johnson and Johnson, Qiagen N.V., Ortho-Clinical Diagnostics, Inc., and Diasorin S.P.A.
Reasons to buy Europe In-Vitro Diagnostics Market Report:
Global, regional and country-level analysis and forecasts of the study market; providing Insights on the geographical areas in which this industry is prospering
Segment-level analysis on basis of product type, application, colour along with market size forecasts and y-o-y estimations to detect key areas of industry growth in detail
Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the market presented in an extensive strategic analyses section containing PESTLE and Porters Five Forces Analyses
A comprehensive listing of key market players along with company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and Analyst overview to study and sustain the market environment
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
Checkout other related studies in the Diagnostics Segment:
Market Data Forecast is a firm working in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. From all-encompassing umbrella markets to extremely specific niche markets covering all the major regions across the globe as part of the research scope, their research services offer one of a kind specialities with competitive pricing options.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
